Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gentler transplant approach offers hope for young patients with rare blood diseases

NCT ID NCT01962415

First seen Jan 04, 2026 · Last updated Apr 30, 2026 · Updated 19 times

Summary

This study tests a milder chemotherapy and transplant method for children and young adults up to age 55 with serious non-cancer blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler approach can safely replace the patient's faulty cells with healthy donor cells while reducing life-threatening side effects. Participants will receive a stem cell transplant from a matched donor and be followed for at least a year to monitor survival, immune recovery, and complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JUVENILE RHEUMATOID ARTHRITIS (JRA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UPMC Children's Hospital of Pittsburgh

    RECRUITING

    Pittsburgh, Pennsylvania, 15224, United States

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.